Boston Trust Walden’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.8M Buy
66,424
+1,474
+2% +$447K 0.22% 156
2026
Q1
$13.9M Buy
64,950
+62,990
+3,214% +$14.1M 0.11% 197
2025
Q4
$336K Hold
1,960
﹤0.01% 353
2025
Q3
$262K Buy
+1,960
New +$208K ﹤0.01% 371
2024
Q3
Sell
-1,960
Closed -$209K 392
2024
Q2
$209K Buy
+1,960
New +$188K ﹤0.01% 373

Other funds holding LRCX

Boston Trust Walden's LRCX Position: Q2 2026 in Review

Boston Trust Walden increased its Lam Research (LRCX) stake by 2.3% in Q2 2026, buying an estimated $447K and bringing the position to 66,424 shares worth $28.8M. The position accounts for 0.22% of the portfolio, ranked #156.

Boston Trust Walden first reported a position in LRCX in Q2 2024 and has held it in 5 quarters since. 3,137 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Boston Trust Walden held 66,424 shares of Lam Research worth $28.8M as of Q2 2026.
  • Boston Trust Walden bought 1,474 Lam Research shares in Q2 2026, an estimated $447K.
  • Lam Research made up 0.22% of Boston Trust Walden's portfolio in Q2 2026, its #156 holding.
  • Boston Trust Walden first reported a position in Lam Research in Q2 2024 and has held it in 5 quarters since.
  • 3,137 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.